Jump to content
  • Sign Up
0
Scott Adams

Alba Therapeutics Recruiting for a Phase 2b Clinical Trial and Gains Exclusive ... - MarketWatch (press release)

Rate this topic

Recommended Posts

Alba Therapeutics Recruiting for a Phase 2b Clinical Trial and Gains Exclusive ...

MarketWatch (press release)

The CeD PRO questionnaire will be used as part of Alba's clinical trial program evaluating its investigational compound larazotide acetate, in patients with Celiac Disease. Alba's Phase 2b clinical study (CLIN1001-012) is currently accepting patients ...

Celiac disease can show up late Jackson Clarion Ledger

Whole Foods preps gluten-free dish Austin News

all 8 news articles »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×